242 filings
8-K
JAGX
Jaguar Health Inc
9 Apr 24
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
5:26pm
8-K
JAGX
Jaguar Health Inc
21 Mar 24
Agreement terms to include payment of double-digit royalties to Jaguar on all Crofelemer products sold in the licensed territory
4:30pm
8-K
JAGX
Jaguar Health Inc
8 Mar 24
Unregistered Sales of Equity Securities
5:00pm
8-K
JAGX
Jaguar Health Inc
1 Mar 24
Entry into a Material Definitive Agreement
5:30pm
8-K
JAGX
Jaguar Health Inc
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
2cbeyt
1 Dec 23
Entry into a Material Definitive Agreement
5:25pm
8-K
afr67pxoyzhexy5umrd
8 Nov 23
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
5:03pm
8-K
uu1qk8z2im6mh
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
pah8jsy ryyik6gnbqc
14 Aug 23
Jaguar Health Reports Second Quarter 2023 Financial Results
9:05am
8-K
a55 1jrxerqi
7 Jul 23
Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders
5:27pm
8-K
wprz9w 2f7t
3 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K
chwxkq8d
19 May 23
Departure of Directors or Certain Officers
5:00pm
8-K
j3cura65vuv
15 May 23
Jaguar Health Reports First Quarter 2023 Financial Results
8:33am
8-K
a2tjqyyfds
12 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
bjm6w9 sv9cdd1shap
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
tzh0rqwto55qtdr
27 Mar 23
Jaguar Health Reports 2022 Financial Results – Prescription Revenues up 179% to $11.9 Million
7:01am
8-K
go3va5mqi4
8 Feb 23
Other Events
8:45am
8-K
zciwn7b8bz
6 Feb 23
Entry into a Material Definitive Agreement
5:01pm
8-K
ddmmujavsks355
20 Jan 23
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
6:13pm
8-K
n5rd54 5khvyz
6 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm